288 related articles for article (PubMed ID: 26975361)
1. Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.
Litou C; Vertzoni M; Goumas C; Vasdekis V; Xu W; Kesisoglou F; Reppas C
Pharm Res; 2016 Jun; 33(6):1399-412. PubMed ID: 26975361
[TBL] [Abstract][Full Text] [Related]
2. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.
Kalantzi L; Goumas K; Kalioras V; Abrahamsson B; Dressman JB; Reppas C
Pharm Res; 2006 Jan; 23(1):165-76. PubMed ID: 16308672
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions.
Pentafragka C; Vertzoni M; Dressman J; Symillides M; Goumas K; Reppas C
Eur J Pharm Sci; 2020 Dec; 155():105535. PubMed ID: 32877722
[TBL] [Abstract][Full Text] [Related]
5. Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
Ono S; Kato M; Ono Y; Imai A; Yoshida T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2009 Apr; 24(4):639-45. PubMed ID: 19032447
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
Rubbens J; Brouwers J; Tack J; Augustijns P
Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
[TBL] [Abstract][Full Text] [Related]
7. Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study.
Pisegna JR; Karlstadt RG; Norton JA; Fogel R; Oh DS; Jay Graepel G; Dorr MB
Dig Dis Sci; 2009 May; 54(5):1041-9. PubMed ID: 18754096
[TBL] [Abstract][Full Text] [Related]
8. Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.
Banerjee R; Reddy DN; Guda NM; Kalpala R; Mahurkar S; Darisetty S; Rao GV
J Gastroenterol Hepatol; 2010 Jan; 25(1):43-7. PubMed ID: 19874444
[TBL] [Abstract][Full Text] [Related]
9. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
Inamori M; Togawa J; Chiguchi G; Abe Y; Kikuchi T; Muramatsu K; Kawamura H; Kobayashi N; Kirikoshi H; Shimamura T; Sakaguchi T; Takamura T; Ueno N; Nakajima A
J Gastroenterol; 2005 Feb; 40(2):213-4. PubMed ID: 15770408
[No Abstract] [Full Text] [Related]
11. Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions.
Sun W; Klamerus KJ; Yuhas LM; Pawlak S; Plotka A; O'Gorman M; Kirkovsky L; Kosa M; Wang D
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):614-626. PubMed ID: 28430398
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults.
Reppas C; Karatza E; Goumas C; Markopoulos C; Vertzoni M
Pharm Res; 2015 Oct; 32(10):3338-49. PubMed ID: 26002744
[TBL] [Abstract][Full Text] [Related]
13. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
[TBL] [Abstract][Full Text] [Related]
14. Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities.
Pedersen PB; Vilmann P; Bar-Shalom D; Müllertz A; Baldursdottir S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):958-65. PubMed ID: 23727368
[TBL] [Abstract][Full Text] [Related]
15. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
16. Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.
Litou C; Psachoulias D; Vertzoni M; Dressman J; Reppas C
Pharm Res; 2020 Jan; 37(3):42. PubMed ID: 31989335
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
18. Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan?
Chan FK
J Gastroenterol Hepatol; 2010 Jan; 25(1):6-7. PubMed ID: 20136970
[No Abstract] [Full Text] [Related]
19. [The effects of preoperative drinking and H2 blocker on gastric acid secretion].
Suzuki A; Kumano H; Osaka S; Shiomi Y; Moroi K; Ishimura N; Nishiwada M
Masui; 1996 Apr; 45(4):445-8. PubMed ID: 8725599
[TBL] [Abstract][Full Text] [Related]
20. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
